21185 ⎘
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies Veterinary vaccine
vaccine
#602Equine influenza virus live attenuated vaccines
#603Immunogenic compositions comprising
#604Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
#605OMPA IN VACCINE COMPOSITIONS AND AS DIAGNOSTIC TARGETS
#606METHOD FOR PREPARING VIRAL PARTICLES WITH CYCLIC DINUCLEOTIDE AND USE OF SAID PARTICLES FOR TREATING CANCER
#607Recombinant HCMV and RHCMV vectors and uses thereof
#608Interleukin-31 monoclonal antibody
#609Combination vaccine against PCV2 and PRRS virus infection comprising albumin
#610CHIMERIC PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINES
#611Attenuated bacterium
#612HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS
#613Vaccine for immunization against Q-fever
#614Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same
#615METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#616Proteins and immunizing compositions containing proteins and methods of use
#617Type II pseudorabies virus attenuated strain, its preparation method and application
#618Reoviridae vaccine
#619Influenza virus mutants and uses therefor
#620Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using
#621Recombinant spike ectodomain proteins, compositions, vectors, kits, and methods for immunizing against avian infectious bronchitis virus
#622Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
#623Gel for treating infectious bronchitis
#624METHODS OF INHIBITING GONAD MATURATION
#625Oil-based adjuvants
#626Cancer vaccines and methods of treatment using the same
#627Polyvalent venom vaccines
#628Porcine reproductive and respiratory syndrome vaccine virus
#629Live bacterial vectors for prophylaxis or treatment
#630Vaccine strains of brachyspira hyodysenteriae
#631Adjuvant compositions
#632POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE
#633COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA
#634Reduced foaming vaccine compositions
#635Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
#636Vaccine against bovine leukemia virus
#637ATTENUATED MANNHEIMIA HAEMOLYTICA STRAINS
#638COCCIDIOSIS VACCINE
#639Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytes
#640PRRSV SX-105 strain and use thereof
#641Genetically engineered swine influenza virus and uses thereof
#642Compositions and methods for vaccination against influenza A virus
#643vaccine
#644Inactivation of viruses by delipidation
#645Attenuated vaccines to protect against tick-borne species infections
#646Filarial nematode vaccines, polypeptides, and nucleic acids
#647Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex
#648Vaccine composition and preparation method and use thereof
#649PCV2 ORF2 carrier platform
#650Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#651Enhanced immune response in porcine species
#652PORCINE EPIDEMIC DIARRHEA VIRUS VACCINES AND METHODS OF USE THEREOF
#653Broad-spectrum vaccine against avian reovirus
#654VACCINES AND DIAGNOSTICS FOR NOVEL PORCINE ORTHOREOVIRUSES
#655Anti-canine TARC antibody used for treatment and diagnosis of canine atopic dermatitis
#656Immunostimulatory plasmids
#657vaccine composition
#658Aquaporin 2 protects cattle from ticks and tick-borne parasites
#659Porcine pestvirus, vaccines, and assays
#660H3 influenza A virus
#661Molecular adjuvant and vaccine
#662Bivalent swine influenza virus vaccine
#663Bacterial vaccine components and uses thereof
#664ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
#665Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
#666CDNA clone-launched platform for high-yield production of inactivated zika virus
#667Herpes simplex virus type-1(HSV-1) vaccine strain VC2 generating an anti-EHV-1 immune response
#668Outer membrane vesicles and uses thereof
#669Live attenuated heterologous vaccine for
#670Cancer vaccine for cats
#671Foot-and-mouth disease vaccine
#672Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#673Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#674Subunit vaccine of porcine pseudorabies virus and preparation method
#675Single-cycle virus for the development of canine influenza vaccines
#676Inactivated canine influenza vaccines and methods of making and uses thereof
#677Treatment of pigs with PCV2 antigen
#678Bird flu vaccine combination comprising virus-like particles and novel adjuvants
#679Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
#680FCV recombinant vaccines and uses thereof
#681PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
#682Nanoparticle based vaccine strategy against swine influenza virus
#683STAPHYLOCOCCAL ANTIGENS
#684Avian reovirus vaccines
#685Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#686Needle-free administration of PRRSV vaccines
#687VACCINE FOR INTRAUTERINE DISEASE
#688elongation factor-1 alpha recombinant immunogenic compositions which induce active protective immunity against avian coccidiosis
#689Altered avian virus for in-ovo inoculation and methods of use thereof
#690Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#691Vaccine containing inactivated cells of mixed with leucocidin
#692Use of the salmonella SPP type III secretion proteins as a protective vaccination
#693Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#694Live attenuated Arkansas serotype infectious bronchitis virus vaccine
#695Piscine myocarditis virus-like particles and methods of use thereof
#696Porcine epidemic diarrhea virus vaccine
#697Method for porcine circovirus production and PCV2 vaccines
#698CAMPYLOBACTER JEJUNI PEPTIDE FOR VACCINE DEVELOPMENT
#699Swine dysentery vaccine
#700Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#701Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccine
#702Microfluidized fragments as an adjuvant and carrier for mucosal vaccine delivery
#703Soft gel delivery method for treating poultry
#704Pestivirus vaccines for congenital tremors
#705Modular antigen transportation molecules and uses therof
#706Vaccine against infection
#707Materials and methods for respiratory disease control in canines
#708FMDV and E2 fusion proteins and uses thereof
#709PCV2 immunogenic compositions and methods of producing such compositions
#710Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#711Compositions and methods of enhancing immune responses to or limiting infection
#712Needleless syringe and method for introducing DNA into injection target area using same
#713Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies
#714Vaccine composition and preparation method and use thereof
#715VACCINE COMPRISING LACTOBACILLUS STRAINS FOR TREATING PROSTATE INFLAMMATION AND BENIGN PROSTATE HYPERPLASIAS
#716Sprayer technology
#717ORAL E. COLI VECTOR-BASED VACCINE FOR PREVENTION OF COCCIDIOSIS IN POULTRY
#718Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
#719Attenuated swine influenza vaccines and methods of making and use thereof
#720Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#721IPN Virus Genome Mutations and Codon Interactions
#722Vaccine Candidates Against Johne's Disease
#723Truncated rotavirus VP4 protein and application thereof
#724Vaccine against porcine parvovirus
#725Immunization of avians by administration of non-replicating vectored vaccines
#726Fungal immunogens and related materials and methods
#727Recombinant vectors expressing antigens of avian influenza virus and uses thereof
#728POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE
#729Mutated
#730DNA vector and transformed tumor cell vaccines
#731Vaccination with anti-tick antigens to control multiple tick species and disease transmission in white-tailed deer and other host animals
#732Promoters
#733Canine adenovirus vectors
#734Swine influenza vaccine
#735EHV insertion site ORF70
#736Whole expressed cell as antigen carrier, and use thereof in preparing vaccine or diagnostic agent, and screening monoclonal antibodies
#737In ovo delivery of probiotic cultures
#738Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom
#739Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#740Pyolysin methods and compositions
#741FGF-23 epitope peptide for improving resistance to breakage and eggshell strength
#742H3 influenza A virus
#743Liposomal adjuvant compositions
#744Vaccine for use against subclinical infection in a pig
#745Recombinant MDV1 and the uses thereof
#746Attenuated vaccines and methods of making and use thereof
#747COMBINATION OF PROTEIN FORMS FOR HORNFLY VACCINATION
#748Vaccines for porcine epidemic diarrhea virus infections
#749Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced
#750Tilapia lake virus vaccines
#751Sheep nematode vaccine
#752Circovirus sequences associated with piglet weight loss disease (PWD)
#753Vaccine for use against subclinical infection in a pig
#754Vaccine against infectious bronchitis virus
#755Infectious pancreatic necrosis virus (IPNV) vaccine compositions
#756Subunit immersion vaccines for fish
#757COMPOSITION COMPRISING PEDV ANTIGENS AND METHODS FOR MAKING AND USING THE COMPOSITION
#758A Rabies Composition Comprising Pika Adjuvant
#759Gene-modified measles virus for tumor treatment use
#760Process for ready-to-use PCV/M.Hyo combination vaccine
#761Recombinant swinepox virus and vaccines
#762Attenuated strain which protects against pathogenic infections, vaccine containing and use thereof
#763PIV5 as an oncolytic agent
#764ATTENUATED LIVE BACTERIA WITH INCREASED ACID RESISTANCE AND METHODS OF USE THEREOF
#765Composition comprising antigens and a mucosal adjuvant and a method for using
#766Lentiviral vector-based Japanese encephalitis immunogenic composition
#767Temperature sensitive multivalent vaccines
#768Compositions and methods related to viral vaccines
#769HVT-vectored ND-IBD vaccine
#770Transgenic mammals and methods of use thereof
#771AGENT FOR CONTROLLING PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME
#772Adjuvant compositions
#773Vaccine for use in protecting a pig against porcine epidemic diarrhea virus
#774Attenuated strains
#775Vaccine for Use in Protecting Offspring of a Sow Against Porcine Endemic Diarrhea Virus
#776vaccine combination
#777Multi-dose compositions containing an antimicrobial polyamide or octenidine preservative
#778Global gene regulators (GGR) as vaccine candidates against
#779Compositions and methods for enhanced innate immunity
#780LPS vaccine
#781FGF-23 epitope peptides and methods of use thereof
#782SERODIAGNOSIS OF SALMON POISONING DISEASE
#783Attenuated bovine coronavirus and related vaccines
#784Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same
#785Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
#786Inactivated equine influenza virus vaccines
#787Method of quickly producing antibodies against avian influenza and maintain antibody titer of duck
#788Attenuated vaccines and methods of making and use
#789Multivalent vaccine for protection against mycobacterial infections and methods of using the same
#790INNATE IMMUNE MODULATING MOLECULE COMPLEX FOR THE ACTIVATION OF THE INNATE IMMUNE SYSTEM OF AQUATIC ANIMALS AND METHODS THEREFOR
#791Antibodies, compositions, and uses
#792Porcine reproductive and respiratory syndrome vaccine virus
#793Multi-indication mRNA cancer immunotherapy
#794Method for minimising progression of cancer in companion animals
#795USE OF SUPERANTIGENS FOR IMPROVING MUCOSAL ALLERGEN SPECIFIC IMMUNOTHERAPY IN NON-HUMAN MAMMALS
#796Newcastle disease virus vectored avian vaccines
#797Antioxidants Against Oxidative Stress During a Stressor Event
#798Vaccine for PCV2 and mycoplasma
#799PCV/mycoplasma hyopneumoniae/lawsonia intracellularis combination vaccine
#800Recombinant adenovirus vectored FMDV vaccines and uses thereof
#801IMMUNOGENIC LHRH COMPOSITION AND USE THEREOF IN PIGS
#802Mycoplasma hyopneumoniae vaccine
#803VACCINE DELIVERY METHOD
#804Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
#805Computationally optimized broadly reactive antigens for influenza
#806Anti-spp. subunit vaccine
#807Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using
#808Dual adjuvant vaccine compositions, preparation and uses
#809Streptococcal GlcNac-lacking gylcopolypeptides, cell wall carbohydrates, vaccines, and methods for making and using them
#810Anti-spp. subunit vaccine
#811Compositions and methods for enterohemorrhagic (EHEC) vaccination
#812Anti-spp. subunit vaccine
#813Anti-spp. subunit vaccine
#814Anti-spp. subunit vaccine
#815Compositions and methods of enhancing immune responses to or limiting infection
#816Composition and method for reducing zoonotic infectious diseases
#817Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus (derzsy's disease)
#818Live attenuated chimeric porcine circovirus vaccine
#819IMMUNE HEALTH FOR COMPANION ANIMALS
#820Immunoreactive glycoprotein GP19 of
#821Hybrid core feline vaccines
#822Influenza virus hemagglutinin protein as a vaccine antigen
#823Vaccination response for immunodeficiency disorders or high cortisol
#824Vaccine against porcine circo virus type 2
#825Immunological compositions containing attenuated
#826Complete genome sequence of the methanogen
#827Genetically engineered swine influenza virus and uses thereof
#828Recombinant swine influenza virus and uses thereof
#829CHIMERIC PESTIVIRUSES
#830Anti-spp. subunit vaccine
#831Mucosal adjuvants and delivery systems
#832FMDV and E2 fusion proteins and uses thereof
#833CMV vectors comprising microRNA recognition elements
#834strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#835Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
#836Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning
#837Attenuated African swine fever virus vaccine
#838Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis
#839Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2
#840Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein
#841HER2 antigenic polypeptide compositions, and methods for their use in treatment and prevention of carcinomas
#842H3 influenza A virus
#843Soft gel delivery system for treating poultry
#844Induction of mucosal tolerance to antigens
#845Vaccine for intrauterine disease
#846In ovo delivery of probiotic cultures
#847Modular antigen transportation molecules and uses thereof in animals
#848Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
#849Prevention and treatment of sub-clinical PCVD
#850Immunizing compositions and methods of use
#851Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure
#852Porcine epidemic diarrhea virus vaccines and methods of use thereof
#853Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#854Compositions produced using enteric pathogens and methods of use
#855Compositions produced using enteric pathogens and methods of use
#856Compositions produced using enteric pathogens and methods of use
#857Methods and materials for treating cancer
#858Particulate formulations for improving feed conversion rate in a subject
#859Immunogenic composition
#860SALMONELLA CHOLERAESUIS-SALMONELLA TYPHIMURIUM VACCINES
#861Combination, composition, and method of administering the combination or composition to animals
#862Parainfluenza virus 5 based vaccines
#863European PRRSV strain
#864Live attenuated vaccine and method of using the same
#865vaccines for congenital tremors
#866Porcine parvovirus
#867Filarial nematode vaccines, polypeptides, and nucleic acids
#868Vaccine
#869Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector
#870Treatment of PRDC in pigs
#871West Nile Virus vaccine
#872Treatment of pigs with PCV2 antigen
#873Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#874Vaccine candidates against johne's disease
#875Recombinant turkey herpesvirus vaccines and uses thereof
#876Chimeric viruses presenting non-native surface proteins and uses thereof
#877Compositions produced using enteric pathogens and methods of use
#878Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytes
#879Koi herpesvirus vaccine
#880Avian reovirus vaccines
#881Vaccine against colibacillosis
#882Swine virus vaccines that are liquid stable
#883Oral virus vaccine
#884Nasal vaccine for
#885Method for the preparation of a vaccinating agent
#886Mutated
#887Production of polypeptides relevant to human and animal health using
#888THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR INFECTIOUS SALMON ANEMIA VIRUS
#889PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
#890Engineered vesicles comprising antigenic peptides and the uses thereof as modulators of immune responses
#891Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
#892Immunogenic compositions comprising
#893COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
#894Aquaporin 2 protects cattle from ticks and tick-borne parasites
#895Tilapia lake virus vaccines
#896REDUCED SATURATED FATTY ACID PROFILES OF RUMINANTS
#897Monoclonal antibodies against the DEC-205 receptor of chicken dendritic cells
#898Poultry virus vaccines that are liquid stable
#899Algal based edible vaccines
#900Attenuated live vaccine against mycoplasmal pneumonia of swine (MPS) and use thereof